Early warning for futile clot removal in stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at how to predict when a clot removal procedure (thrombectomy) might not work well for acute ischemic stroke. The goal is to build an early warning system so doctors can better decide on treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have an acute ischemic stroke (confirmed by brain scan).
- You must be eligible for a clot removal procedure (thrombectomy).
- You must not have dementia or severe disability prior to this stroke.
- You must not have a life-limiting illness (like advanced cancer) expected to shorten your life to less than 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a procedure called endovascular thrombectomy (clot removal through a catheter) for people with very large strokes. It aims to see if removing the clot can help even when a large part of the brain is already damaged.
This trial tests if removing a large blood clot from the brain up to 3 days after a stroke improves recovery compared to standard medical care alone. It is for patients who have a severe stroke and are otherwise healthy enough for the procedure.
This trial tests a procedure to remove a large blood clot in the brain (mechanical thrombectomy) for people who have a very large stroke. It aims to see if removing the clot can improve recovery, even for those with severe strokes.
This trial tests whether removing a blood clot from a large brain artery is better than standard medical care for people who have a mild stroke (NIHSS score 2-5) but still have symptoms like trouble speaking, weakness, or confusion. It is for patients who can be treated within 24 hours of their last known well time.
This study tests a special catheter (a thin tube) designed to remove blood clots from large arteries in the brain during a stroke. The goal is to see if it is safe and effective at restoring blood flow.
This trial tests a brain-protective approach given through an artery during treatment for an acute ischemic stroke when clot removal (endovascular therapy) is planned. It may help reduce brain injury related to the stroke and procedure.
Hear when a new Endovascular Thrombectomy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.